Inactivation of Clostridium difficile Cytotoxin by the Neutrophil Myeloperoxidase System

The cytotoxin of Clostridium difficile was examined for sensitivity to oxidant secretory products of neutrophils. Exposure to myeloperoxidase, H2O2, and a halide resulted in loss of toxin activity measured by tissue-culture cytotoxicity. The peroxide requirement was provided by reagent H2O2, a perox...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 149; no. 2; pp. 215 - 219
Main Authors: Ooi, Winnie, Levine, Harold G., LaMont, J. Thomas, Clark, Robert A.
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 01-02-1984
University of Chicago Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The cytotoxin of Clostridium difficile was examined for sensitivity to oxidant secretory products of neutrophils. Exposure to myeloperoxidase, H2O2, and a halide resulted in loss of toxin activity measured by tissue-culture cytotoxicity. The peroxide requirement was provided by reagent H2O2, a peroxide-generating enzyme (glucose oxidase), or a peroxide-producing intestinal microorganism, Lactobacillus acidophilus. Human neutrophils stimulated by phorbol myristate acetate caused similar toxin inactivation. In both the cell-free and the neutrophil systems, inactivation of toxin required halides and was abrogated by azide, cyanide, or catalase. Neutrophils from patients with lack of myeloperoxidase or failure to produce H2O2 were impaired in toxin inactivation unless myeloperoxidase or H2O2, respectively, was added. The reducing agent 2-mercaptoethanol enhanced toxin activity. These data suggest a similarity between C difficile cytotoxin and the classic thiol-activated cytolysins. Moreover, they raise the possibility that neutrophils are involved in oxidative detoxification of microbial products.
Bibliography:Informed consent was obtained from all normal and patient subjects, and the study protocol was approved by the Institutional Review Board for Human Subjects using US Department of Health and Human Services guidelines.
ark:/67375/HXZ-ZJ7CCX3X-8
istex:88FE193529B1D6F7B00551DC3973B440DBDC6580
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/149.2.215